Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
August-2020 Volume 20 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2020 Volume 20 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Estrogen downregulates TAK1 expression in human fibroblast‑like synoviocytes and in a rheumatoid arthritis model

Corrigendum in: /10.3892/etm.2022.11149
  • Authors:
    • Xi Li
    • Miao Li
  • View Affiliations / Copyright

    Affiliations: Department of Sports Medicine and Joint Surgery, The People's Hospital of China Medical University, Shenyang, Liaoning 110000, P.R. China, Department of Microbiology and Parasitology, College of Basic Medical Sciences, China Medical University, Shenyang, Liaoning 110122, P.R. China
  • Pages: 1764-1769
    |
    Published online on: June 5, 2020
       https://doi.org/10.3892/etm.2020.8848
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Transforming growth factor β‑activated kinase‑1 (TAK1), a member of the mitogen‑activated protein kinase family, plays a key role in the pathogenesis and progression of rheumatoid arthritis (RA). Estrogen has been previously reported to delay arthritis progression. However, the exact association between TAK1 and estrogen remains elusive. The present study demonstrated that TAK1 was upregulated in synoviocytes of patients with RA compared with patients with osteoarthritis and healthy controls. In addition, TAK1 was also expressed in cultured fibroblast‑like synoviocytes (FLS), and its levels decreased significantly in 17β‑estradiol (E2)‑treated cells in a dose‑dependent manner. Furthermore, administration of E2 significantly decreased TAK1 expression and attenuated the development of collagen‑induced arthritis (CIA). Taken together, the findings of the present study suggested that E2 mediates a decrease of TAK1 in both FLS and CIA, which subsequently results in a suppression of the pathological process of CIA. Therefore, estrogen may serve as a potential therapeutic agent for the treatment of RA by targeting TAK1.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Viatte S, Plant D and Raychaudhuri S: Genetics and epigenetics of rheumatoid arthritis. Nat Rev Rheumatol. 9:141–153. 2013.PubMed/NCBI View Article : Google Scholar

2 

Juarez M, Filer A and Buckley CD: Fibroblasts as therapeutic targets in rheumatoid arthritis and cancer. Swiss Med Wkly. 142(w13529)2012.PubMed/NCBI View Article : Google Scholar

3 

Huh JE, Seo BK, Park YC, Kim JI, Lee JD, Choi DY, Baek YH and Park DS: WIN-34B, a new herbal medicine, inhibits the inflammatory response by inactivating IκB-α phosphorylation and mitogen activated protein kinase pathways in fibroblast-like synoviocytes. J Ethnopharmacol. 143:779–786. 2012.PubMed/NCBI View Article : Google Scholar

4 

Xu L, Feng X, Tan W, Gu W, Guo D, Zhang M and Wang F: IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients. Arthritis Res Ther. 15(R170)2013.PubMed/NCBI View Article : Google Scholar

5 

Yoshioka Y, Kozawa E, Urakawa H, Arai E, Futamura N, Zhuo L, Kimata K, Ishiguro N and Nishida Y: Suppression of hyaluronan synthesis alleviates inflammatory responses in murine arthritis and in human rheumatoid synovial fibroblasts. Arthritis Rheum. 65:1160–1170. 2013.PubMed/NCBI View Article : Google Scholar

6 

Hammaker DR, Boyle DL, Inoue T and Firestein GS: Regulation of the JNK pathway by TGF-beta activated kinase 1 in rheumatoid arthritis synoviocytes. Arthritis Res Ther. 9(R57)2007.PubMed/NCBI View Article : Google Scholar

7 

Choi YS, Park JK, Kang EH, Lee YK, Kim TK, Chung JH, Zimmerer JM, Carson WE III, Song YW and Lee YJ: Cytokine signaling-1 suppressor is inducible by IL-1beta and inhibits the catabolic effects of IL-1beta in chondrocytes: Its implication in the paradoxical joint-protective role of IL-1beta. Arthritis Res Ther. 15(R191)2013.PubMed/NCBI View Article : Google Scholar

8 

Geurts J, van den Brand BT, Wolf A, Abdollahi-Roodsaz S, Arntz OJ, Kracht M, van den Berg WB and van de Loo FA: Toll-like receptor 4 signalling is specifically TGF-beta-activated kinase 1 independent in synovial fibroblasts. Rheumatology (Oxford). 50:1216–1225. 2011.PubMed/NCBI View Article : Google Scholar

9 

Alamanos Y and Drosos AA: Epidemiology of adult rheumatoid arthritis. Autoimmun Rev. 4:130–136. 2005.PubMed/NCBI View Article : Google Scholar

10 

Engdahl C, Jochems C, Windahl SH, Börjesson AE, Ohlsson C, Carlsten H and Lagerquist MK: Amelioration of collagen-induced arthritis and immune-associated bone loss through signaling via estrogen receptor alpha, and not estrogen receptor beta or G protein-coupled receptor 30. Arthritis Rheum. 62:524–533. 2010.PubMed/NCBI View Article : Google Scholar

11 

Holmdahl R, Carlsten H, Jansson L and Larsson P: Oestrogen is a potent immunomodulator of murine experimental rheumatoid disease. Br J Rheumatol. 28 (Suppl 1):54–58; discussion 69-71. 1989.PubMed/NCBI View Article : Google Scholar

12 

Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:315–324. 1988.PubMed/NCBI View Article : Google Scholar

13 

Villeneuve E, Nam J and Emery P: 2010 ACR-EULAR classification criteria for rheumatoid arthritis. Rev Bras Reumatol. 50:481–483. 2010.

14 

Bartok B, Boyle DL, Liu Y, Ren P, Ball ST, Bugbee WD, Rommel C and Firestein GS: PI3 kinase δ is a key regulator of synoviocyte function in rheumatoid arthritis. Am J Pathol. 180:1906–1916. 2012.PubMed/NCBI View Article : Google Scholar

15 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔ C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

16 

Kim JM, Shin SC, Park GC, Lee JC, Jeon YK, Ahn SJ, Thibeault S and Lee BJ: Effect of sex hormones on extracellular matrix of lamina propria in rat vocal fold. Laryngoscope. 30:732–740. 2020.PubMed/NCBI View Article : Google Scholar

17 

Andersson A, Grahnemo L, Engdahl C, Stubelius A, Lagerquist MK, Carlsten H and Islander U: IL-17-producing γδT cells are regulated by estrogen during development of experimental arthritis. Clin Immunol. 161:324–332. 2015.PubMed/NCBI View Article : Google Scholar

18 

Gottar-Guillier M, Dodeller F, Huesken D, Iourgenko V, Mickanin C, Labow M, Gaveriaux S, Kinzel B, Mueller M, Alitalo K, et al: The tyrosine kinase BMX is an essential mediator of inflammatory arthritis in a kinase-independent manner. J Immunol. 186:6014–6023. 2011.PubMed/NCBI View Article : Google Scholar

19 

Tedeschi SK, Bermas B and Costenbader KH: Sexual disparities in the incidence and course of SLE and RA. Clin Immunol. 149:211–218. 2013.PubMed/NCBI View Article : Google Scholar

20 

Islander U, Jochems C, Lagerquist MK, Forsblad-d'Elia H and Carlsten H: Estrogens in rheumatoid arthritis; the immune system and bone. Mol Cell Endocrinol. 335:14–29. 2011.PubMed/NCBI View Article : Google Scholar

21 

Kvien TK, Uhlig T, Ødegård S and Heiberg MS: Epidemiological aspects of rheumatoid arthritis: The sex ratio. Ann N Y Acad Sci. 1069:212–222. 2006.PubMed/NCBI View Article : Google Scholar

22 

Khosla S, Melton LJ III, Atkinson EJ and O'Fallon WM: Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab. 86:3555–3561. 2001.PubMed/NCBI View Article : Google Scholar

23 

Jung SM, Kim KW, Yang CW, Park SH and Ju JH: Cytokine-mediated bone destruction in rheumatoid arthritis. J Immunol Res. 2014(263625)2014.PubMed/NCBI View Article : Google Scholar

24 

Cutolo M, Accardo S, Villaggio B, Clerico P, Bagnasco M, Coviello DA, Carruba G, lo Casto M and Castagnetta L: Presence of estrogen-binding sites on macrophage-like synoviocytes and CD8+, CD29+, CD45RO+ T lymphocytes in normal and rheumatoid synovium. Arthritis Rheum. 36:1087–1097. 1993.PubMed/NCBI View Article : Google Scholar

25 

Cutolo M, Capellino S, Montagna P, Sulli A, Seriolo B and Villaggio B: Anti-inflammatory effects of leflunomide in combination with methotrexate on co-culture of T lymphocytes and synovial macrophages from rheumatoid arthritis patients. Ann Rheum Dis. 65:728–735. 2006.PubMed/NCBI View Article : Google Scholar

26 

Dubey RK, Tofovic SP and Jackson EK: Cardiovascular pharmacology of estradiol metabolites. J Pharmacol Exp Ther. 308:403–409. 2004.PubMed/NCBI View Article : Google Scholar

27 

Cutolo M, Villaggio B, Bisso A, Sulli A, Coviello D and Dayer JM: Presence of estrogen receptors in human myeloid monocytic cells (THP-1 cell line). Eur Cytokine Netw. 12:368–372. 2001.PubMed/NCBI

28 

Peng R, Dai W and Li Y: Neuroprotective effect of a physiological ratio of testosterone and estradiol on corticosterone induced apoptosis in PC12 cells via Traf6/TAK1 pathway. Toxicol In Vitro. 50:257–263. 2018.PubMed/NCBI View Article : Google Scholar

29 

Andersson A, Stubelius A, Karlsson MN, Engdahl C, Erlandsson M, Grahnemo L, Lagerquist MK and Islander U: Estrogen regulates T helper 17 phenotype and localization in experimental autoimmune arthritis. Arthritis Res Ther. 17(32)2015.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li X and Li M: Estrogen downregulates TAK1 expression in human fibroblast‑like synoviocytes and in a rheumatoid arthritis model Corrigendum in /10.3892/etm.2022.11149. Exp Ther Med 20: 1764-1769, 2020.
APA
Li, X., & Li, M. (2020). Estrogen downregulates TAK1 expression in human fibroblast‑like synoviocytes and in a rheumatoid arthritis model Corrigendum in /10.3892/etm.2022.11149. Experimental and Therapeutic Medicine, 20, 1764-1769. https://doi.org/10.3892/etm.2020.8848
MLA
Li, X., Li, M."Estrogen downregulates TAK1 expression in human fibroblast‑like synoviocytes and in a rheumatoid arthritis model Corrigendum in /10.3892/etm.2022.11149". Experimental and Therapeutic Medicine 20.2 (2020): 1764-1769.
Chicago
Li, X., Li, M."Estrogen downregulates TAK1 expression in human fibroblast‑like synoviocytes and in a rheumatoid arthritis model Corrigendum in /10.3892/etm.2022.11149". Experimental and Therapeutic Medicine 20, no. 2 (2020): 1764-1769. https://doi.org/10.3892/etm.2020.8848
Copy and paste a formatted citation
x
Spandidos Publications style
Li X and Li M: Estrogen downregulates TAK1 expression in human fibroblast‑like synoviocytes and in a rheumatoid arthritis model Corrigendum in /10.3892/etm.2022.11149. Exp Ther Med 20: 1764-1769, 2020.
APA
Li, X., & Li, M. (2020). Estrogen downregulates TAK1 expression in human fibroblast‑like synoviocytes and in a rheumatoid arthritis model Corrigendum in /10.3892/etm.2022.11149. Experimental and Therapeutic Medicine, 20, 1764-1769. https://doi.org/10.3892/etm.2020.8848
MLA
Li, X., Li, M."Estrogen downregulates TAK1 expression in human fibroblast‑like synoviocytes and in a rheumatoid arthritis model Corrigendum in /10.3892/etm.2022.11149". Experimental and Therapeutic Medicine 20.2 (2020): 1764-1769.
Chicago
Li, X., Li, M."Estrogen downregulates TAK1 expression in human fibroblast‑like synoviocytes and in a rheumatoid arthritis model Corrigendum in /10.3892/etm.2022.11149". Experimental and Therapeutic Medicine 20, no. 2 (2020): 1764-1769. https://doi.org/10.3892/etm.2020.8848
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team